chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient began to feel sick and dizzy about 15 minutes after vaccine was administered.  She very nearly collapsed but pharmacy staff quickly laid her down with feet up and she was given water and a sucker.  She soon began to feel better.  After a few minutes she was able to sit up and was fully recovered after 30 minutes
Note: company is Seqirs, Quad prep in single dose syringe. Not sure if Fluad or Afluria. Cannot fully read Lot # on my consent/administration sheet.  Injection was not easily pushed into Lt deltoid. I started itching w/in 5 minutes on Lt forearm, first noticed by nurse who gave the injection. Itching moved to Lt cheek, then forehead and Rt cheek.  Injection site pain persisted. A thick post nasal drip trying to drain in back of throat. About 60 min post injection,  severe Lt deltoid pain, frontal/bitemporal headache, itching on head/scalp and then buttocks. Also new severe pain and new swelling, and associated limited ROM Rt knee (I'm approx 3 months post op from arthroscopic surgery) and Lt ankle with severe pain , swelling ROM (approx 2 months post op from hardware removal after initial surgery from severe ankle Fx in Feb 2021).  General feeling that something is not right beyond the acute symptoms.  I saw my PCP on 10/30/21 who found the residual of the increased acute inflammation in Rt knee, Lt ankle and also in Rt ankle (no h/o injury).
Info has been received from an RN concerning a 4 year old Caucasian male with no pertinent medical history and no drug allergies who on 4/21/05 was vaccinated, SC in the left lower thigh, with the 1st 0.5ml dose of varicella virus vaccine live. Concomitant therapy included DTAP, poliovirus vaccine inactivated and MMRII. The varicella virus vaccine live had expired on 4/17/05. It was reported that the pt experienced no adverse reaction but the RN did report slight soreness at the site on the day of administration, which only lasted for one day. Unspecified medical attention was sought. The RN noted that the pt's mother declined re-vaccination and no other problems were noted. No product quality complaint was involved. Additional info is not expected.
Grandmother states found child arm red and swollen about 12 noon on 8/12/06. Child c/o pain. On 8/13/06 grandmother stated a small amount of blisters appeared so cold pack was applied for about 10 minutes. Child appeared with father today, left arm red, swollen and moderate amount of vesicles. Redness measuring about 10cm x 7 cm. No fever complaints just pain.
+ erythematous, macular lesion, few vesicular lesions, urticarial type rash on neck/ torso/ upper extremities.
pt recv vax in 1991 & again a/starting kindergarten;recv MMR II on 2NOV91 & had no immunity for mumps
stomachache; diarrhea; high temperature/fever; headache; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Oct2023 as dose 1, single (Batch/Lot number: unknown) intramuscular for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DIARRHOEA (non-serious) with onset Oct2023, outcome "not recovered", described as "diarrhea"; HEADACHE (non-serious) with onset Oct2023, outcome "unknown"; PYREXIA (non-serious) with onset Oct2023, outcome "unknown", described as "high temperature/fever"; ABDOMINAL PAIN UPPER (non-serious) with onset Oct2023, outcome "unknown", described as "stomachache". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of abdominal pain upper, diarrhoea, pyrexia, headache.  Additional information: Patient called about the Pfizer Covid Vaccine 2023-2024 formula 12 years and up and wanted to know if diarrhea, high temperature, stomachache and headache are side effects of the vaccine. She said she may had other symptoms, said she could not keep anything in her stomach and kept having constant diarrhea. Advised her that Pfizer does not provide treatment recommendations and so they referred her to her doctor/HCP for further management. She understood. She was not sure but believes it was the Pfizer 12 and over covid vaccine that she received about a week ago. She was having a strong reaction which she describe as including high temperature, pooping her brains out and a stomach ache. She had a headache. She may had other symptoms that she cannot think of right now. She was curious because she was having such a strong reaction and she was not sure if it was a side effect and maybe it could be some other sort of virus or stomach virus. Someone just came and brought her medicine. She was not sure it was a reaction to the covid vaccine. She declined report and requested to be transferred to ask if the symptoms that she had were side effects of the covid vaccine. The nurse sent the stool sample. At present she was in a rehab facility and jokingly states since she got a new her. Declined to provide address.  The information on the batch/lot number for bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
Severe URI Sx: nasal congestion, sore throat, persistent cough, rhinorrhea, headache, low grade fever, chills, myalgia, general malaise............6-7 out 11 clinic staff vaccinated also came down with varying degree of URI/flu-like Sx's.
Patient noticed pruritis and erythema on the injection site this morning when taking a shower. Patient only noticed this morning.
This initial spontaneous report was received on 06-NOV-2017 from a lawyer regarding a case in litigation and refers to a female patient of unknown age. Medical history, concurrent conditions, and concomitant medications were not provided. On or about 14-JAN-2014, the patient was inoculated (by an unspecified person) with ZOSTAVAX as recommended for routine adult health maintenance and for the prevention of shingles (dose, route of administration, site of administration and lot # were not provided). The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 19-NOV-2016, she was treated (by an unspecified healthcare professional) at a medical center (facility) for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as severe herpes zoster, or shingles. The patient sought subsequent treatment for ongoing and worsening symptoms, where she received a second diagnosis of new shingles outbreaks (Date not reported). The female patient has been prescribed VALTREX for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was not resolved. The lawyer felt the events were related to ZOSTAVAX. Additional information has been requested.
Pt was given a ZOSTAVAX vaccination. 5-10 mins after pt felt dizzy and was sweating heavily. Blood pressure was taken and was read as 66/44 - pulse 45. Epipen 0.3mg was given IM. Paramedic was called in and pt was taken to the hospital.
Narrative:  Patient received second COVID vaccine on 9/9/21 (first COVID  vaccine administered 2/10/21). Patient also received influenza vaccine 10/26/21.  Immunizations were administered in left deltoid. Patient developed rash/hives on  right arm and back. No new medications noted.
The site of injection with induration, swelling, redness, warmth & tenderness. Healing gradually with BENADRYL & cold compresses.
Passed out; A spontaneous report was received from a consumer concerning an 80-years-old male patient who received Moderna's COVID-19 vaccine (mRNA-1273) and passed  out/loss of consciousness.  Patient's medical history was not reported. Concomitant product use was not provided by the reporter.  On 17 Feb 2021, approximately 17 hours prior to onset of the event, the patient received their first of two planned doses of mRNA-1273 (lot/batch number: 023M20A) for prophylaxis of COVID-19 infection.  On 18 Feb 2021, the patient experienced medically significant event of passed out. No treatment information was provided.  Action taken with mRNA-1273 in response to the event was not reported.  The outcome of the event passed out was not reported.; Reporter's Comments: Very limited information regarding this event has been provided at this time.  Further information has been requested.
This spontaneous report was received from a physician via a company representative, and refers to an unspecified number of patients of unknown age. The patients' medical history and concurrent conditions were not provided. It was reported that on unknown date, unspecified number of patients younger than 2 years of age were vaccinated with a dose of PNEUMOVAX 23 injection (expiration date, dose and route of administration were not reported). Concomitant therapies were not provided. It was stated that the physician's nurses denied that the physician has administered PNEUMOVAX 23 to patients under the age of 2 years. Furthermore, it was reported that the physician and the nurse may be confusing PNEUMOVAX 23 with PREVNAR. However, no adverse event was reported. Additional information has been requested.
swelling of (most likely) lymph nodes in left armpit (same arm as vaccination); This is a spontaneous report from a contactable consumer (patient). A 43-years-old female patient (no pregnant) received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) , via an unspecified route of administration on 20Jan2021 14:15 at SINGLE DOSE at Left arm for covid-19 immunisation .  Medical history included basal cell carcinoma.  Concomitant medication included l-arginine [arginine].  The patient experienced swelling of (most likely) lymph nodes in left armpit (same arm as vaccination) on 21Jan2021 17:00. No treatment for the event. The outcome of event was not recovered.    Information on the lot/batch number has been requested.
Information has been received from a physician and an LPN concerning a 14 year old female who on 05-MAR-2007 at 10:45 a.m. was vaccinated in the right deltoid with the first 0.5 mL dose of Gardasil (lot# 655619/1427F). Concomitant vaccination given in the right deltoid on 05-MAR-2007 included MENACTRA (lot # U1947AA). It was reported that the patient was vaccinated on day 4 of her menses. Her menses stopped for 2 days and re-started on 07-MAR-2007 and continued through 13-MAR-2007 (described as a normal cycle. During this time she had normal cramps and no treatment was given. Her cycle returned to normal occurring 28 days later. The patient reported that she is on a normal 28-day menstrual cycle since the age of 13 years. The patient was not on birth control. No further information is expected.
Information has been received from a pharmacist and a patient safety manager concerning an 8 year old female who at 10:45 a.m., on 26-JUN-2008 was vaccinated with a dose of ZOSTAVAX (Oka/Merck) instead of VARIVAX (Oka/Merck). The patient had been seen since then by her primary care physician on 27-JUN-2008 and 01-JUL-2008. She was fine with no adverse experiences. She was scheduled for VARIVAX (Oka/Merck) in 6 months. The patient safety manager felt this was a case of human error. Both vaccines are stored in the same freezer, though on separated shelves. They do a large volume of vaccinations and can be quite busy. The patient safety manager's senior management has issued an alert to other military bases to be careful to avoid such incidences. They have since placed "high alert" tags on the vaccine to remind the staff to be careful not to confuse ZOSTAVAX (Oka/Merck) and VARIVAX (Oka/Merck). This is one of several reports from the same source. The patient's sibling was also vaccinated with a dose of ZOSTAVAX (Oka/Merck) instead of VARIVAX (Oka/Merck) (WAES 0807USA00781). Additional information is not expected.
This case was reported by a pharmacist and described the occurrence of bruise injection site in a subject of unspecified age and gender who was vaccinated with FLUARIX. On 11 October 2012 the subject received a dose of FLUARIX (.5 ml, subcutaneous, unknown arm) and experienced inappropriate route of vaccination. FLUARIX should be administered as an intramuscular injection and not injected subcutaneously. In October 2012, less than a week since vaccination with FLUARIX, the subject experienced bruise injection site, and swelling injection site. The reporter was not able to provide specific details as to the onset of the adverse events. At the time of reporting the outcome of the events was unknown. The pharmacist reported four cases with inappropriate route of vaccination, bruise injection site and swelling injection site. The pharmacist did not know if there were more than four employees that were given FLUARIX by subcutaneous route versus intramuscular route. See cases A0998038A, A0998039A, and A0998040A.
There aren't any adverse events, pt. is doing good. She is 1 of 2 patients that received Menveo that day, 1 of the 2 was given the orange top (powder) with a sterile diluent instead of using the grey top (solution Menveo comes with). Both MA's stated they didn't do it so we are not able to know who received the right dose and who didn't.
About 5-6 hours after PEDIARIX, Hib, PCV, rotavirus; Petechiae - Required hospitalization 2x days.  06/18/2008 MR received for DOS 5/16-18/2008 with DX: Rash.  R LE swelling 2' to vaccinations-local reaction. Infant presented from local hospital with petechial rash on arms, legs and feet with mottled skin. Sepsis w/u (-). Rash noted as purplish macular rash by hospitalist.
got sick but it was not full blown flu, much milder; Initial information regarding an unsolicited valid non-serious case received from a consumer (patient) via social media on 19-Oct-2020.  This case is linked to case 2020SA296404 (cluster).  This case involves a patient of unknown demographics who got sick but it was not full blown flu, much milder (Influenza), while the patient received Influenza Vaccine.  The patient's medical history, past medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medication was unknown.  On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (lot number and expiration date were not reported) via unknown route in unknown administration site as prophylactic vaccination.  On an unknown date, the patient got sick but it was not full blown flu, much milder (Influenza) (non serious), unknown latency following administration with INFLUENZA VACCINE.  No laboratory data was provided.  It was not reported if the patient received a corrective treatment.  The event outcome was unknown, at the time of reporting.  There will be no information about the batch number in this case.
Started with sore arm and fever, chills, nausea, muscle and body aches, and dizziness. fever lasted until 1/14/2021. and every thing else lasted 1/15/2021.
Blotchy red rash across shoulders and upper chest area. Largest noted to be dime sized. 3-4 inch area of concentrated redness around injection site. Took Benadryl and Tylenol the morning of 11/11/07, and Benadryl in the evening. Rash faded considerably. All symptoms resolved on 11/13/07.
This case was reported by a healthcare professional and described the occurrence of Guillain Barre syndrome in a 36-year-old female subject who was vaccinated with FLUARIX (GlaxoSmithKline). On 14 October 2008 the subject received unspecified dose of FLUARIX (unknown). On 26 October 2008, 12 days after vaccination with FLUARIX, the subject experienced Guillain Barre syndrome, numbness and tingling. At an unspecified time after vaccination with FLUARIX, the subject experienced side weakness, left or right sided facial weakness, degenerative lumbar disc disease and decreased reflexes. The subject was admitted to the hospital with the diagnosis of right sided weakness. The subject began to experience symptoms of numbness and tingling in extremities on 26 October 2008. Treatment included IV fluids, IV immunoglobulin, brain MRI with and without contrast and lumbar puncture. No abnormalities of the brain were noted. Lumbar degenerative disc disease was present. History and physical noted ascending numbness decrease in reflexes and right-sided facial weakness. The subject was hospitalized on 06 November 2008. The subject was treated with intravenous fluid(s) and normal immunoglobulin. At the time of reporting the outcome of the Guillain Barre syndrome, side weakness, left or right sided facial weakness, numbness, tingling, degenerative lumbar disc disease and decreased reflexes was unspecified.
The patient answered another patient's name and entered the privacy area for the vaccination .  Before  the administration of the  COVID-19  vaccine , the patient was asked to confirm his date of birth and that he was getting the Pfizer-BioNTech and he said yes. After the vaccine has been administered to him. We now called the name of the next patient but no body answered until another patient asked if it is his turn to be vaccinated and while asking him questions we discovered that the first patient had answered his name and got a first dose of Pfizer vaccine instead of the second dose of the Moderna COVID-19 Vaccine that he should have gotten if he had answered his correct name.
PATIENT FELT NAUSEA, VOMITTING AND FEELING WARM AND DIZZY, PT RECOVERED SHORTLY
CHILLS; FEVER; This spontaneous report received from a patient concerned a 48 year old female. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known allergies. The patient received tylenol (form of admin, route of admin, and batch number were not reported) dose and frequency were not reported from 11-MAR-2021 for an unspecified indication. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 805031, and batch number: 805031) dose was not reported, once a total administered on 11-MAR-2021 08:55 for prophylactic vaccination. No concomitant medications were reported. On 11-MAR-2021, the subject experienced fever. Laboratory data included: Body temperature (NR: not provided) 100.1 (units unspecified). Treatment medications included: paracetamol. On 11-MAR-2021 16:30, the subject experienced chills. The action taken with covid-19 vaccine ad26.cov2.s, and tylenol was not applicable. The patient recovered with sequelae from fever on 11-MAR-2021, and had not recovered from chills. This report was non-serious. This case, involving the same patient is linked to 20210322068.
Full dose instead of a half dose; Five doses (lot # 017C21A) of the Moderna Covid-19 Vaccine were given to patients today; This spontaneous case was reported by a nurse and describes the occurrence of ACCIDENTAL OVERDOSE (Full dose instead of a half dose) and PRODUCT STORAGE ERROR (Five doses (lot # 017C21A) of the Moderna Covid-19 Vaccine were given to patients today) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 017C21A, 011M20A and 037K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 29-Oct-2021, the patient experienced ACCIDENTAL OVERDOSE (Full dose instead of a half dose) and PRODUCT STORAGE ERROR (Five doses (lot # 017C21A) of the Moderna Covid-19 Vaccine were given to patients today). On 29-Oct-2021, ACCIDENTAL OVERDOSE (Full dose instead of a half dose) and PRODUCT STORAGE ERROR (Five doses (lot # 017C21A) of the Moderna Covid-19 Vaccine were given to patients today) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant treatment was reported.  No treatment medication was reported.   Most recent FOLLOW-UP information incorporated above includes: On 29-Oct-2021: Added updated fax number and added event information, narrative was generated accordingly.
At 48 hours, had raised, red, hot area measuring 3 1/2" wide x 2" high. Have taken flu shots yearly x 10 years but never the high dose. Never had a problem with regular strength.
Upon receiving shot hot a small lump and was itching.  Subsided in a couple of days.  Day 8 woke up with   2 in raised lump , red, itching.
Immediately after vaccine administration patient turned pale said he was lightheaded advised him to lay down. As patient laid down he had near syncope episode. His eyes were open but unable to speak or hear. Patient alert and vocal in 8-10 seconds. Patient had not eaten breakfast and fear of needles. Monitored BP and pulse for 30 min. Patient ate several (2) popsicles and was able to leave office (walking) and went home to eat and he was doing well at discharge without any symptoms.
8 days post vaccine 2/25, my arm started to hurt again in late afternoon early evening, as it did the first 24-48 hours of the injection date. By the time I went to sleep, it was uncomfortable to sleep on that side, and it started to itch a bit. The next day (2/26, day 8 post injection) I had flu-like symptoms - very bad headache, fatigue, body aches, and slightly elevated temp (99.4-99.9) - general malaise. I took some Advil in the evening to help with the headache and general malaise and it worked. My arm still hurt and was itchy on and off. By Saturday (2/27, day 9) the flu like symptoms were mostly gone (yay), but I woke up with  a large, red, slightly raised bump and was itchy on and off at the injection site. It was BRIGHT RED and HOT to the touch. Today, day 10, it is still red but a much more dull red, and not as hot to touch, and doesn't hurt as much. So I think it's clearing up! I should note that I once had a very similar reaction to a flu shot, about 5 years ago, and thus continue to get my  flu shot in the doctor's office just to be safe, and I sit for 15 minutes to ensure I don't get a reaction. I had a red, warm, itchy welt around the injection site. The reaction I had with my flu shot was also several days after the injection, but not as many as the Moderna shot.  I have read that this is called "Covid arm" and a known reaction which is comforting, but I wanted to be sure to report it BECAUSE SCIENCE is important. I also understand this should not deter me from getting my second dose, but I am curious to know if I should expect the same reaction? The article I read suggested getting the second dose in the OPPOSITE arm, which would be my dominant arm (I am a lefty.) I am hoping someone from VAERS can advise me if I should switch arms, or even delay my vaccine. Right now, dose two is scheduled for 3/17, 4 weeks after my first dose. Thank you.
generalized pain; pain in the joints; headache; pain in the injection site; dizzy; cloudy mind; warm sensation.; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A female patient of an unspecified age received first dose of bnt162b2 (PFIZER-BIONTECH COVID -19 VACCINE, Solution for injection, Lot Number and Expiry date was not reported) via an unspecified route of administration on 24Mar2021 as dose 1, single for COVID-19 immunization. Medical history included allergic reactions to medications. The patient concomitant medications were not reported. On 24Mar2021, immediately after vaccination patient felt dizzy with a cloudy mind and a generalized warm sensation. Patient also felt generalized pain, pain in the joints, headache and pain in the injection site since the administration of the vaccine. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.